Australia PBS To Cover Merck, Janssen Hep C Drugs, Five Others
This article was originally published in PharmAsia News
Executive Summary
Australia's Pharmaceutical Benefits Scheme has decided to cover drugs for treating five additional diseases, including two for hepatitis C, and said it would increase the price of nine other drugs.